FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 257 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR The right combination for early detection August 4, 2021 Dr Ian Walker on Smoking: ‘An unequal burden, but a fixable... March 31, 2023 The long road to targeting the holy grail of the immune... November 9, 2020 A Chemotherapy-Free Regimen of Tucatinib and Trastuzumab Shows Antitumour Activity with... January 29, 2025 Load more HOT NEWS Mouse Study Links Immune Cells to Diarrhea Caused by Chemotherapy New study to investigate breast cancer in ethnic minority groups Does Sugar Cause Cancer? Indigenous Women with Early Stage Breast Cancer Get Mastectomies at Higher...
